Score Your Stock

MGRC MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

0155.KL · Health Care · Health Care Equipment & Services
Bottom 32% of scored stocks
Compare with nearby peers
WeakBottom 32% of scored stocks
ShariahWeak SpotRecent Loss

MGRC scores 38/100 on fundamentals: in the bottom 32% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (100/100); its weakest is Price Fairness (0/100). It carries 2 warning flags: Weak Spot, Recent Loss.

Best
Financial 100
Weakest
Price 0
  • Carries a Weak Spot flag
  • Carries a Recent Loss flag
Mkt capRM 50.6m#900 of 1113 in BursaEPSRM 0.00P/E94.3×✗ vs sector avg 23.2×P/B2.5×✗ vs sector avg 1.7×Div yieldNo dividends paidBottom 26% in Bursa52w range · 78% of range0.150.39
as of 18 Oct 2026

Nearby peers

Ranks #24 of 30 in Health Care by score

#1DPHARMA85#22IHH40#23DCHCARE39
#24MGRC38
#25HEXCARE38#26ADVENTA31

One-Minute Summary

Why MGRC scores 38

A financially strong, expensively priced stock with shrinking sales, but price fairness needs attention.

What looks good
What to watch

After Jun '26 results: 29 → 30+1· Quarterly Momentum Weak → StrongSee all movers →

Business Strength

30
Why 30?
Pillar score: (0 + 0 + 0 + 1 + 2) = 3 of 10 points → 30
Return on Equity (ROE)3%Weak4-Year Revenue Growth-29%/yrWeak4-Year Profit Growthn/m (loss-making)WeakNet Profit Margin5%OkayQuarterly Momentum+74%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -93.1%Equity ↓ -45.9%ROE % 2.5%
Net ProfitEquityROE %
7m-4m-2m1m37m18m16m20m202220242025TTM19.5%-23.1%-15.2%2.5%

Revenue & Net Profit, with Net Margin

Revenue ↓ -64.4%Net Profit ↓ -93.1%Net Margin % 5%
RevenueNet ProfitNet Margin %
28m6m8m10m7m-4m-2m1m202220242025TTM25.4%-76.4%-30%5%

Sales shrank about 64.4% over 4 years: the business is getting smaller, which needs a good explanation.

The company lost money in recent years: the bars below zero are losses, not profits.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +78.6%Net Profit ↑ +177.8%Net Margin % 28%
RevenueNet ProfitNet Margin %
1m1m1m2m3m2m3m3m-1m0m-1m0m0m-2m1m1mSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26-64.3%-38.5%-53.8%-22.2%16%-70.8%40.7%28%
▼▼▼▼▲▼▲▲

Sales grew about 78.6% over the last 8 quarters: customers keep spending more with this company.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 100?
Pillar score: (2 + 2 + 2) = 6 of 6 points → 100
Debt-to-Equity0.1×StrongCurrent Ratio5.7×StrongInterest Coverage6.6×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -31.2%Equity ↓ -45.9%D/E 0.1×
Total DebtEquityD/E
2m2m1m1m37m18m16m20m202220242025TTM0×0.1×0.1×0.1×

Borrowings fell about 31.3% over 4 years: the company is steadily getting safer.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -55.5%Current Liabilities ↑ +35.3%Current Ratio 5.8×
Current AssetsCurrent LiabilitiesCurrent Ratio
30m12m10m13m2m4m3m2m202220242025TTM17.7×3.2×3.2×5.8×
Why 38?
Pillar score: (0 + 1 + 1 + 1) = 3 of 8 points → 38
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive but bumpyOkayCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +2,100%Free CF ↑ +253.8%
Operating CFFree CF
0m-1m1m2m-1m-1m1m2m202220242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↓ -79%Short-Term Debt ↓ -25%Total Debt ↓ -31.2%
CashShort-Term DebtTotal Debt
21m0m1m4m0m0m0m0m2m2m1m1m202220242025TTM

Dividends per Share, with Yield

DPS (sen) → +0%Yield % 0%
DPS (sen)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 0?
Pillar score: (0 + 0 + 0) = 0 of 6 points → 0
P/E Ratio94.3×WeakP/B Ratio2.5×WeakPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.38RM 0.28RM 0.18100500Oct '25Feb '26Jun '26Oct '26📊📊💰

The share price is up about 45.7% over the past year.

What happened, and how the price moved

Why 25?
Pillar score: (0 + 2 + 1 + 0 + 0 + 0) = 3 of 12 points → 25
Earnings ConsistencyVery bumpyWeakDebt Trend (4yr)FallingStrongShare Count Trend (4yr)+7%/yrOkayInventory vs Sales (4yr)+41.9 pp/yr vs salesWeakAsset Turnover Trend (4yr)-32.2%WeakQuarterly ConsistencyLoss in 5 of 8 quartersWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↓ -64.4%Inventory ↑ +100%Inv. % of Rev. 7.9%
RevenueInventoryInv. % of Rev.
28m6m8m10m0m1m0m1m202220242025TTM1.4%16.4%5%7.9%

Get an email when MGRC's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #24 of 30 in Health Care by score

Sector peers

#1DPHARMA85#22IHH40#23DCHCARE39
#24MGRC (you)38
#25HEXCARE38#26ADVENTA31

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B Ratio
2026RM 10.1mRM 0.5mRM 2.2mRM 2.0mRM -0.1mRM 4.3mRM 1.1mRM 0.3mRM 20.0mRM 13.4mRM 2.3mRM 22.0mRM 3.1mRM 0.8m-3%5%0.1×5.7×6.6×---
2025RM 8.0mRM -2.4mRM 1.1mRM 1.0mRM -0.1mRM 1.0mRM 1.2mRM 0.3mRM 15.8mRM 9.5mRM 3.0mRM 18.7mRM 3.9mRM 0.4mRM 0.0m-15%-30%0.1×3.2×-25.0×0%-13.8×2.1×
2024RM 5.5mRM -4.2mRM -0.7mRM -1.0mRM -0.2mRM 0.3mRM 1.6mRM 0.4mRM 18.2mRM 11.6mRM 3.6mRM 22.4mRM 4.8mRM 0.9mRM 0.0m-23%-76%0.1×3.3×-36.9×0%-11.5×2.7×
2022RM 28.4mRM 7.2mRM 0.1mRM -1.3mRM -1.3mRM 20.5mRM 1.6mRM 0.4mRM 37.0mRM 30.1mRM 1.7mRM 41.9mRM 2.9mRM 0.4mRM 0.0m19%25%0.0×18.1×61.7×0%13.2×2.6×